eyeWatch Pen
eyeWatch Pen
The eyeWatch Pen is the control unit of the eyeWatch system. It allows, with simple geastures, the measurement and adjustment of the eyeWatch's functional position. The unit works for both left and right eyes and can be handled with just a single hand.
The eyeWatch Pen is the control unit of the eyeWatch system. It allows, with simple geastures, the measurement and adjustment of the eyeWatch's functional position. The unit works for both left and right eyes and can be handled with just a single hand.
Contact us
Where to find us:
Rheon Medical SA
EPFL Innovation park, Building B
1015 Lausanne
Switzerland
Please complete this form. We will get back to you as soon as possible.
Nikos Stergiopulos
Founder & CEO
Professor of Bioengineering at EPFL and medical device expert and entrepreneur. Nikos has founded/co-founded Endoart (treatment of morbid obesity, aquired by Allergan Inc.), Antlia (developer of implantable drug delivery pumps), RT-Safe (radiotherapy technology) and Comphya (neurostimulation for erectyle dysfunction). Nikos brings to Rheon 20 years of experience in medical device development, from an early concept to a full clinical implementation.
Adan Villamarin
COO
Adan has received his PhD in Bioengineering at EPFL in 2014. He supervises the technical, pre-clinical and clinical development of the eyeWatch system.
Stéphane Bigler
CTO
Designer and co-inventor of the eyeWatch implant. Stéphane brings to Rheon more than 20 years of experience in the design and development of precision micro-devices.
Constantinos Stergiopulos
R&D Director
Constantinos received his MS in Microengineering from EPFL in 2014. He is in charge of R&D and new product development.